Epilepsy Society praises Government decision to review handling of concerns around sodium valproate
Epilepsy Society's chief executive Clare Pelham has praised the Government's decision to announce a forward-looking review that will address the way the healthcare system has handled the concerns of patients in its care and make certain that lessons are learned and history does not repeat itself.
EMA publishes recommendations on sodium valproate
New measures to avoid the exposure of unborn babies to the epilepsy drug sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Clare Pelham joins expert group on sodium valproate
Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.
MPs debate safety issues around sodium valproate in House of Commons
Although we could not see them as we watched today's sodium valproate debate via Parliament Live TV, the presence of three women -Janet Williams, Emma Murphy and Deborah Mann - as they sat in the public gallery, was very much felt in the House of Commons.
Health secretary Jeremy Hunt sends second letter to Epilepsy Society
Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt, calling for mandatory reviews for women and girls of childbearing age taking sodium valproate.
Arlene Foster and DUP support Epilepsy Society sodium valproate campaign
Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure mandatory reviews for all women and girls of childbearing who take sodium valproate.